← Back to all trials
Not Yet Recruiting
NCT05603481
CGM in Patients With ED's
Conditions: Anorexia Nervosa Restricting Type, Anorexia Nervosa, Binge Eating/Purging Type, ARFID, Avoidant Restrictive Food Intake Disorder
Sex: All
Ages: 18 Years – 65 Years
Enrollment: 50
Sponsor: Denver Health and Hospital Authority
Summary
To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).
Eligibility Criteria
Inclusion Criteria:Ages 18-65 and meet the DSM-V criteria for AN-R or AN-BP or ARFIDAdmission %IBW ≤ 75%Exclusion Criteria:Diagnosed with an eating disorder other than AN-R or AN-BP or ARFID%IBW > 75% on admissionInability to give informed consent to participate/lacks decisional capacityUnable to follow the study protocolTransferred to the unit on a mental health hold/short term certificationTreatment team refusal of patient's participation
Source: ClinicalTrials.gov (NCT05603481). StuddyBuddy aggregates publicly available trial information.
